Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Gyros Protein Technologies appoints Mark Vossenaar as VP European Sales
Gyros Protein Technologies appoints Mark Vossenaar as VP European Sales
Rondo-Pak hires new Senior VP of Sales and Marketing
Rondo-Pak hires new Senior VP of Sales and Marketing
Packaging industry veteran David Phillipes joins healthcare sector provider of folding cartons and printed components
GammaDelta Therapeutics expands management team
GammaDelta Therapeutics expands management team
Paolo Paoletti leads as Chief Executive Officer
CBA elects new chair
CBA elects new chair
Timothy de Gavre appointed new Sandoz UK Country Head
Timothy de Gavre appointed new Sandoz UK Country Head
Appointment of biosimilars expert demonstrates commitment of Sandoz to these important medicines
Metrion Biosciences appoints Chief Operating Officer and Head of Business Development
Metrion Biosciences appoints Chief Operating Officer and Head of Business Development
Andrew Southan promoted to Chief Operating Officer and James Beaumont joins Metrion as Head of Business Development
Lisa Anson becomes new ABPI President
Lisa Anson becomes new ABPI President
DiaMedica appoints Nancy Chang to its Strategic Advisory Board
DiaMedica appoints Nancy Chang to its Strategic Advisory Board
TrakCel appoints Joe Vitale to Director of Process Engineering
TrakCel appoints Joe Vitale to Director of Process Engineering
Tetra Bio-Pharma appoints Denis Courchesne as VP Sales
Tetra Bio-Pharma appoints Denis Courchesne as VP Sales
New President and Chief Legal Officer of Cognosante Ventures
New President and Chief Legal Officer of Cognosante Ventures
Modus Therapeutics appoints Ellen Donnelly as CEO
Modus Therapeutics appoints Ellen Donnelly as CEO
VANC appoints Alan Arnstein to Board of Directors
VANC appoints Alan Arnstein to Board of Directors
Medicines Discovery Catapult makes four senior hires to management team
Medicines Discovery Catapult makes four senior hires to management team
Four more leading figures from the life sciences sector have joined the Medicines Discovery Catapult to complete the Senior Management line-up
Karolinska changes Chair and CEO
Karolinska changes Chair and CEO
Karolinska Development announces Chair Bo Jesper Hansen and CEO Jim Van heusden’s decision to step down
Claudio Carini joins the FNIH Biomarkers Consortium Steering Committees
Claudio Carini joins the FNIH Biomarkers Consortium Steering Committees
The Consortium aims to accelerate the development of biomarker-based technologies
Previous
1
…
76
77
78
79
(current)
80
81
82
…
213
Next
Trending Articles
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
MHRA scientific leader recognised in 2026 King's Birthday Honours
Dr Nicola Rose receives OBE for services to science and public health
Servomex appoints new Global Sales Director
Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
Alfa Laval appoints new managing director to drive strategic growth
Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all